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Background: Dexmedetomidine has a sedative analgesic property without respiratory depression. This study 
evaluated the efficacy of dexmedetomidine as an appropriate sedative drug for monitored anesthesia care (MAC) in 
outpatients undergoing cataract surgery on both eyes compared with combination of propofol and alfentanil.
Methods: Thirty-one eligible patients were randomly divided into two groups on the first operation day. 
Dexmedetomidine was administered in group D at 0.6 μg/kg/h, and propofol and alfentanil was infused 
concomitantly in group P at a rate of 2 mg/kg/h and 20 μg/kg/h, respectively. Sedation was titrated at Ramsay 
sedation score 3. Iowa satisfaction with anesthesia scale (ISAS) of the patients was evaluated postoperatively. Systolic 
blood pressure (SBP), heart rate (HR), respiration rate (RR), and peripheral oxygen saturation (SpO2) were recorded 
throughout the surgery. For the second operation, the group assignments were exchanged. 
Results: Postoperative ISAS was 50.3 (6.2) in group D and 42.7 (8.7) in group P, which was statistically significant (P < 
0.001). SBP was significantly lower in group D compared with group P from the beginning of the operation. HR, RR, 
and SpO2 were comparable between the two groups. There were 8 cases (25.8%) of hypertension in group P, and 1 
case (3.2%) in group D (P < 0.05). In contrast, 1 case (3.2%) of hypotension and 1 case (3.2%) of bradycardia occurred 
in group D. 
Conclusions: Compared with the combined use of propofol and alfentanil, dexmedetomidine could be used 
appropriately for MAC in cataract surgery with better satisfaction from the patients and a more stable cardiovascular 
state. (Korean J Anesthesiol 2011; 61: 453-459)
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Introduction
Cataract surgery can be performed safely under monitored 
anesthesia care (MAC) with or without local anesthesia [1]. 
Several drugs, such as propofol, benzodiazepine, and opioids 
have been used for MAC either alone or in combination [2-4]. 
Benzodiazepine may cause excessive sedation and confusion 
especially in elderly patients [5], and propofol can also result in 
disorientation and excessive sedation [6]. Because these drugs 
have no analgesic component, overdose with a rescue opioid 
is often given to prevent the unintentional reflex to painful 
stimuli, and thus may result in a higher incidence of confusion, 
excessive sedation, or disorientation. Additionally, respiration is 
depressed more often when additional opioids are used.
Considering that most of the patients undergoing cataract 
surgery are elderly, the above-mentioned aspects can be serious 
potential problems. Based on the analysis of the American 
Society of Anesthesiologists Closed Claims database, overdose 
of sedative or opioid leading to respiratory depression was the 
most common (24%) in MAC claims, and 40% of these resulted 
in permanent brain damage or death [7]. 
Dexmedetomidine is a novel selective α2 receptor agonist that 
produces sedation and analgesia without causing respiratory 
depression [8]. It also allows patients to respond to verbal 
commands during the sedation; easy conversion from sleeping 
to awakening is possible [9]. Therefore, dexmedetomidine 
has been used in various clinical fields, such as sedation in 
the intensive care unit, radiologic examination of pediatric 
patients, awake intubation, shockwave lithotripsy, endoscopic 
examination [10-14] and as an adjuvant to anesthetics [15,16].
Accordingly, we evaluated the efficacy of dexmedetomidine 
as an appropriate sedative drug for MAC in outpatients 
undergoing cataract surgery, which included a survey of the 
patients’ satisfaction.
Materials and Methods
This study was approved by the Institutional Review Board 
and all participants gave written informed consent for this 
study. This trial was conducted in adult outpatients aged 
between 20 and 75 years. They were American Society of 
Anesthesiologists (ASA) classification I, II, or III and scheduled 
for sequential cataract surgery on both eyes under MAC. 
Preoperative exclusion criteria were pregnancy, kidney or 
hepatic disease, chronic medication with analgesic or sedative 
drug, or history of alcohol or drug abuse.
On the first operation day, patients were randomized to 
receive either dexmedetomidine (group D) or combination 
of propofol and alfentanil (group P). Patients fasted at least 8 
hours before the operation and did not receive any preoperative 
sedative drug. On arriving at the operating room, standard 
monitoring, including electrocardiography, non-invasive 
arterial pressure, and peripheral pulse oximetry was applied. 
Oxygen was administered via nasal cannula at 5 L/min. Topical 
anesthesia using sterile 0.5% proparacaine HCl ophthalmic 
solution was applied to the eye of patients.
Patients of group D received 0.6 μg/kg/h of dexmedetomidine, 
and patients of group P were given 2 mg/kg/h of propofol and 
20 μg/kg/h of alfentanil concomitantly. Dexmedetomidine was 
diluted in 2 μg/ml in normal saline for group D, and 100 mg of 
propofol and 1,000 μg of alfentanil were mixed to become total 
12 ml volume for group P. Each drug was titrated every 5 min to 
Ramsay sedation scale 3 during the operation (Appendix 1) [17]. 
Administration of dexmedetomidine was adjusted by 0.1 μg/
kg/h, and mixture of propofol and alfentanil were adjusted by 
0.3 mg/kg/h and 3 μg/kg/h, respectively. Ephedrine 5 mg was 
administered when systolic blood pressure (SBP) decreased 
below 90 mmHg or 70% of the preoperative value, and 
nicardipine 1 mg was given when SBP went over 160 mmHg or 
130% of the preoperative value. Atropine 0.5 mg was injected to 
the patients when heart rate (HR) fell below 40 beats/min.
The infusion was stopped at the end of the surgery in both 
groups. In the recovery center for outpatients, patients were 
asked to answer the 11 questions of Iowa satisfaction with 
anesthesia scale (ISAS) using a 6 point rating scale (Appendix 2) 
[18] at least 1 hour after the operation. It was performed by one 
anesthesiologist who was blinded to the group assignment. 
SBP, HR, respiratory rate (RR), and peripheral oxygen 
saturation (SpO2) were recorded at each time point as follows; 
T1 = preoperative baseline, T2 = anesthesia start, T3 and T4 
= 5 and 10 min after anesthesia, T5 = operation start, T6, T7, 
and T8 = 5, 10, and 15 min after operation, T9 = postoperative 
value. Moreover, the incidence of adverse events including 
hypertension (SBP > 160 mmHg), hypotension (SBP < 90 mmHg), 
bradycardia (HR < 50 beats/min), respiratory depression (RR < 
10 breaths/min), and oxygen desaturation (SpO2 < 93%) were 
evaluated. 
The second operation was performed one or two weeks later. 
On the second operation day, patients previously in one group 
were assigned to the opposite group. Except for the exchange of 
infused drugs, all other methods were identical to the first trial.
The primary effect variable, used for power calculation 
analysis, was the difference of ISAS. With an assumption of a 
difference in means of 5.0 and a SD of 6.8 (data not shown), 
and aiming at a power of 80% and a risk of 0.05 for type I error, 
31 patients in each group were required. Data were presented 
as mean ± SD. ISAS was compared using Mann-Whitney U 
test. Hemodynamic and respiratory data were analyzed using 
repeated measures ANOVA, and when a significant inter-group 
difference was found, the Mann-Whitney U test was used at 455 www.ekja.org
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each time points. The Fisher’s exact test was used to determine 
the incidence of adverse events. Statistical analyses were 
performed using SPSS 15.0 version (SPSS Inc, Chicago, IL) and 
P values of <0.05 were considered statistically significant.
Results
A total of 52 patients were recruited, and 11 patients of these 
were excluded from this study. After initiation of the study, 10 
patients dropped out of the study (Fig. 1). Finally, 16 patients 
were arranged in order, beginning with group P at the first 
operation and then group D at the second operation. The other 
15 patients were assigned first to group D and next to group 
P. The characters of subdivided groups at first operation are 
presented in Table 1, and no significant differences were seen 
between the groups. Total anesthesia time was 36.0 ± 6.1 min in 
group D and 38.2 ± 7.3 min in group P, and operation time was 
21.0 ± 5.6 min and 20.7 ± 5.1 min in group D and P, respectively. 
These were comparable between the two groups. 
Postoperative ISAS was 50.3 ± 6.2 in group D and 42.7 ± 8.7 
in group P with significant difference (P < 0.001). Median (inter-
quartile range) values of ISAS were 50 (48-55) vs. 45.0 (39-49) 
for group D vs. group P, respectively (Fig. 2), indicating more 
satisfactory condition in group D.
Fig. 1. Enrollment of patients.
Table 1. Patients’ Characteristics at the First Operation
Group P (n = 16) Group D (n = 15)
Age
Height
Weight
Gender (M/F)
ASA (I/II/III)
57.4 ± 13.4
162.4 ± 6.5
67.8 ± 10.3
8/8
5/7/4
60.8 ± 11.4
160.8 ± 8.7
64.0 ± 12.7
5/10
4/8/3
At the second operation, the group assignment were exchanged. 
The data are expressed as mean ± SD or patient number. Group P: 
combined use of propofol and alfentanil. Group D: use of dexme-
detomidine. 456 www.ekja.org
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Changes of hemodynamic and respiratory variables are 
presented in Fig. 3. Initial SBPs were not different between the 
two groups (130 ± 15 mmHg for group D vs. 133 ± 19 mmHg 
for group P, P = 0.603). However, SBP was significantly lower 
in group D (117 ± 16, 117 ± 17, 114 ± 15, 112 ± 14, and 107 ± 15) 
compared with group P (129 ± 19, 129 ± 18, 127 ± 18, 126 ± 15, 
and 129 ± 18) from the beginning of the operation (P < 0.05). 
HR, RR and SpO2 were comparable between two groups. 
There were 8 cases (25.8%) of hypertension in group P, and 
1 case (3.2%) in group D (P < 0.05). In contrast, 1 case (3.2%) of 
hypotension and 1 case (3.2%) of bradycardia occurred in group 
D. In group D, hypotension in one patient occurred only once 
during the entire period and the lowest SBP was 85 mmHg. The 
lowest HR in a patient of group D who showed bradycardia was 
40 beats/min. No episodes of respiratory depression or oxygen 
desaturation were observed in either group.
Discussion
In this study, our results suggest that dexmedetomidine is 
an effective and safe drug for MAC in outpatients undergoing 
cataract surgery. Dexmedetomidine has been used in short 
or long term sedation in the intensive care unit, sedation 
for various procedures, or as a supplementary drug during 
Fig. 2. Box plot of Iowa satisfaction with anesthesia scale of both 
groups. Group P: combined use of propofol and alfentanil. Group D: 
use of dexmedetomidine. *P < 0.05 compared with group P.
Fig. 3. Changes of hemodynamic and respiratory variables. Group P: combined use of propofol and alfentanil, Group D: use of 
dexmedetomidine. T1: baseline, T2: anesthesia start, T3 and T4: 5 and 10 min after anesthesia, T5: operation start, T6, T7, and T8: 5, 10, and 15 
min after operation, T9: postoperation. Black circle: group D, white square: group P. *P < 0.05 in group P vs. group D.457 www.ekja.org
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general anesthesia. Previous studies have reported that 
dexmedetomidine can also be used effectively in cataract 
surgery.
Ayoglu et al. [19] demonstrated that intraocular pressure 
was decreased and satisfactory sedation and analgesia were 
achieved by a sole loading infusion of 1 μg/kg dexmedetomidine 
for 10 min preoperatively. Apan et al. [20] also reported that 
dexmedetomidine made the intraoperative HR more stable 
and postoperative pain less severe compared with midazolam, 
thus it was appropriate for sedation and analgesia during MAC 
in cataract surgery. On the contrary, Alhashemi [21] reported 
that dexmedetomidine was not suitable compared with 
midazolam because it accompanied cardiovascular depression 
and delayed the discharge from the recovery room. In that 
study, dexmedetomidine was administered with 1 μg/kg over 
10 min and infused at 0.1-0.7 μg/kg/h during the surgery. It 
was thought that relatively high loading dose and infusion rate 
might have caused cardiovascular suppression. 
Use of loading dose of dexmedetomidine is still controversial 
because of the development of cardiovascular depression. 
Dexmedetomidine at a rate of 0.25-2 μg/kg resulted in a 
reduction of arterial pressure and cardiac output, although 
large doses (1 or 2 μg/kg) of dexmedetomidine produced the 
initial increase of arterial pressure temporarily, presumably 
due to peripheral vasoconstriction [22]. In this current study, 
loading dose of dexmedetomidine was omitted. There were 
results reporting that appropriate sedation and stable hemo-
dynamics were achieved in the absence of loading dose of 
dexmedetomidine [23], and the incidence of hypotension was 
decreased in ICU sedation without the loading dose [24]. 
Considering that cataract surgery is less invasive and takes 
a short time, loading dose of dexmedetomidine is thought to 
cause postoperative hypotension more frequently, thus only 
continuous infusion was initiated and adjusted depending on 
the Ramsay sedation scale of patients during the operation. 
Therefore, severe hypotension did not occur intra- and 
postoperatively, and there was no profound sedation delaying 
discharge. On the other hand, intraoperative arterial pressure 
was kept stable without additional requirement of anti-
hypertensive drug. 
Additionally, the subjective satisfaction score by ISAS in 
group D was higher than that of group P. Dexmedetomidine 
enables the patient to convert easily between sedative and 
cooperative state; therefore, cooperative sedation makes 
patients more comfortable during the cataract surgery. When 
propofol and alfentanil were used, immediate interactions 
with the surgeon did not go smoothly due to the patients’ 
sedated state; however inadequate sedation would lead 
to patient discomfort. In this study, we did not check the 
surgeon's satisfaction. However, dexmedetomidine’s property 
of cooperative sedation may enable the surgeon to perform 
surgery more efficiently.
In this study, one could raise doubt about the doses of drugs 
between two groups. Dexmedetomidine can be administered 
as a continuous infusion of 0.2-0.7 μg/kg/h following 1 μg/kg 
loading infusion over 10 min [8]. It has been suggested that 1-2 
mg/kg/h of propofol infusion may achieve a satisfactory level 
for conscious sedation [25], and propofol infusion of 25-50 μg/
kg/min in combination with alfentanil infusion of 0.2-0.4 μg/
kg/min was recommended for sedation and analgesia during 
MAC in healthy outpatients undergoing breast biopsy [26]. The 
drug infusion rates of previous studies are comparable with 
those in this study, and the drug infusion rate was titrated to the 
Ramsay sedation score of 3. Therefore, it seems not to influence 
the outcomes of this study. 
Dexmedetomidine is unique in that it does not cause res-
pira  tory depression because its mechanism is not mediated 
by the γ-aminobutyric acid system [8]. It has been proved in 
critically ill patients given dexmedetomidine during surgery as 
well as those given the drug for short term [27,28]. In addition 
to this singular property of dexmedetomidine, less use of 
rescue sedative or analgesic drugs might also contribute to less 
respiratory depression. In the present study, total anesthesia 
time was around 30 min. It was not a very long period; however, 
intraoperative RR and SpO2 of group D were somewhat 
superior to group P. Most of the patients were outpatients 
and elderly, thus we suggest that dexmedetomidine has more 
advantages over other commonly used sedatives. In addition 
to previous affirmative results [20,29] such as sedative plus 
analgesic properties, stable hemodynamic state, and low 
IOP, dexmedetomidine should be recommended for MAC in 
cataract surgery.
Combined use of benzodiazepine and opioid may be 
associated with a potential risk for developing delirium, 
whereas, dexmedetomidine can minimize the occurrence of 
delirium in critically ill or elderly patients. The incidence of 
delirium was 50% in patients receiving propofol or midazolam 
for postoperative sedation; however, only 3% of patients 
receiving dexmedetomidine presented postoperative delirium 
[30]. This is yet another advantage of dexmedetomidine as a 
sedative in patients with high risks of delirium.
In conclusion, we showed that dexmedetomidine seems 
to be an acceptable agent for MAC in outpatients undergoing 
cataract surgery. Compared with propofol/alfentanil, 
dexmedetomidine reduced arterial pressure during the period 
of operation. Satisfaction scores were also in favor of the 
patients treated with dexmedetomidine.458 www.ekja.org
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Appendix 1. Ramsay Sedation Scale [17]
1: Patient is anxious and agitated or restless, or both.
2: Patient is cooperative, oriented, and tranquil.
3: Patient responds to command only.
4: A brisk response to a light glabella tap or a loud auditory stimulus.
5: A sluggish response to a light glabella tap or a loud auditory stimulus.
6: No response to a light glabella tap or a loud auditory stimulus.
Appendix 2. Iowa Satisfaction with Anesthesia Scale [18]
I threw up or felt like throwing up.*
I would have the same anesthetic again.
I itched.*
I felt relaxed.
I felt pain.*
I felt safe.
I was too hot or cold.*
I was satisfied with the anesthesia care.
I felt pain during surgery.*
I felt good.
I hurt.*
Each item uses 6 point response scored from 1 to 6 (disagree very 
much, disagree moderately, disagree slightly, agree slightly, agree 
moderately, agree very much). *The scores were reversed in negative 
questions.